A Comparative Study on Efficacy of Intraocular Pressure Lowering of Two Fixed-Dose Antiglaucoma Drug Combination Brinzolamide-Brimonidine Versus Latanoprost-Timolol in Primary Open-Angle Glaucoma and Ocular Hypertension
Journal of Ocular Pharmacology and Therapeutics · 2024
DOI: 10.1089/jop.2023.0186 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Avinash Mishra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Military Hospital, Jalandhar, India. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Intraocular Pressure, Ocular Hypertension, Latanoprost. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Purpose
To compare the efficacy of Brinzolamide-Brimonidine (BB) (1%+0.2%) with the gold standard Latanoprost-Timolol (LT) (0.005%+0.5%) in treating primary open-angle glaucoma (POAG) and ocular hypertension (OHT).
Methods
A 1-year prospective study, spanning from May 2022 to May 2023, conducted at a tertiary eye-care hospital. Participants, aged 40-60, with a baseline intraocular pressure (IOP) >21 mm Hg, requiring a >30% reduction, were enrolled. Group A (n = 100) received BB, and Group B (n = 100) received LT. Outcomes were assessed at 1 month (IOP difference from baseline), 3 and 6 months (mean diurnal variations).
Results
The mean age at presentation was 55.5 ± 4.5 years in Group A and 54.7 ± 4.2 years in Group B. At 1 month, Group A exhibited a mean IOP of 18.7 mm Hg, while Group B had 17.6 mm Hg, with no statistically significant difference (P = 0.53). No significant diurnal variation was observed in either group (P = 0.07). Target pressure was achieved in 88% of patients in Group A and slightly higher at 92% in Group B. Moreover, no serious side effects were reported, and compliance was higher in Group B (98%) compared to Group A (96%).
Conclusion
Although LT showed slightly better and sustained IOP reduction, the difference was not statistically significant. Both BB and LT demonstrated comparable outcomes for managing POAG and OHT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Military Hospital, Jalandhar, India.
- Department of Ophthalmology, Military Hospital, Jammu, India.
- Department of Ophthalmology, Military Hospital, Danapur, India.
- Department of Ophthalmology, Sitapur Eye Hospital, Sitapur, India.
ORCID-Profile: Mohini Agrawal
Zitieren
APA
Mishra, A., Agrawal, M., Tripathi, A., Bhirud, A., Kumar, L. C. R., & Vinod K, B. B. (2024). A Comparative Study on Efficacy of Intraocular Pressure Lowering of Two Fixed-Dose Antiglaucoma Drug Combination Brinzolamide-Brimonidine Versus Latanoprost-Timolol in Primary Open-Angle Glaucoma and Ocular Hypertension. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2023.0186
Vancouver
Mishra A, Agrawal M, Tripathi A, Bhirud A, Kumar LCR, Vinod K BB. A Comparative Study on Efficacy of Intraocular Pressure Lowering of Two Fixed-Dose Antiglaucoma Drug Combination Brinzolamide-Brimonidine Versus Latanoprost-Timolol in Primary Open-Angle Glaucoma and Ocular Hypertension. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2023.0186
BibTeX
@article{Mishra2024,
author = {Mishra, Avinash and Agrawal, Mohini and Tripathi, Anchal and Bhirud, Atul and Kumar, Lt Col Rajnish and Vinod K, Brig Baranwal},
title = {A Comparative Study on Efficacy of Intraocular Pressure Lowering of Two Fixed-Dose Antiglaucoma Drug Combination Brinzolamide-Brimonidine Versus Latanoprost-Timolol in Primary Open-Angle Glaucoma and Ocular Hypertension},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2024},
doi = {10.1089/jop.2023.0186}
}
EUVIMED